Nalaganje...

Myelomonocytic leukaemia following cyclophosphamide therapy of rheumatoid disease.

A 69-year-old woman treated for 31 months with daily oral cyclophosphamide for refractory rheumatoid disease developed acute myelomonocytic leukemia 21/2 years after stopping the drug. The possibility of a casual association between the therapy and subsequent leukaemia is supported by the growing ex...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Love, R R, Sowa, J M
Format: Artigo
Jezik:Inglês
Izdano: 1975
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1006477/
https://ncbi.nlm.nih.gov/pubmed/1062969
Oznake: Označite
Brez oznak, prvi označite!